Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2020-10-02 Regulatory Filings
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
DMS Biotech participe à l'effort collectif contre le coronavirus
Regulatory Filings Classification · 97% confidence The document is a press release dated 02/10/2020 announcing that DMS Biotech is participating in efforts against the coronavirus by studying therapeutic solutions for ARDS using anti-inflammatory cytokines from adipose-derived stem cells. It details a research partnership negotiation with Inserm units. This type of announcement, focusing on a specific operational development, research progress, or corporate news that is not a mandatory periodic financial filing (like 10-K or IR) or a standard earnings release (ER), fits best under the general 'Regulatory Filings' (RNS) category, which often serves as a catch-all for significant, non-standard corporate news releases, especially when the content is operational/scientific rather than purely financial or governance-related. Given the short length and nature as a news announcement, it is not a full report (like AR or IR).
2020-10-02 French
Mise à disposition du rapport financier semestriel 2020
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) stating that the company has made its semi-annual financial report available to the public and filed it with the AMF. It does not contain the actual financial statements or data, but rather directs the reader to the company website to access the report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA). H2 2020
2020-09-30 French
Rapport financier semestriel 2020
Interim / Quarterly Report Classification · 100% confidence The document is a 'Rapport financier semestriel 2020' (Semi-annual financial report) for Groupe DMS. It contains comprehensive financial statements, including the balance sheet, income statement, cash flow statement, and notes to the financial statements for the period ending June 30, 2020. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2020
2020-09-30 French
Progression des résultats semestriels 2020
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive report detailing the company's financial performance for the first half of 2020 (S1 2020). It includes consolidated financial statements (Income Statement, Balance Sheet), management's analysis of business trends, operational highlights, and outlook. It is not a mere announcement of a report, as it contains the actual financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report. H1 2020
2020-09-30 French
DMS Biotech se développe à Hong Kong avec son partenaire WKK International Limited
Regulatory Filings Classification · 95% confidence The document announces a commercial agreement between DMS Biotech (a division of DMS Group) and WKK International Ltd. for the exclusive distribution of Adip'sculpt and Stemcis solutions in Hong Kong. This announcement details a strategic business development, partnership, and initial operational results (surgical interventions). It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It describes a significant business transaction and expansion, which aligns best with a general corporate announcement or a filing related to strategic activities. Since there is no specific category for 'Partnership Announcement' or 'Business Development,' and the content is a press release detailing a commercial agreement, it falls under the general regulatory announcement category, RNS, as a fallback for significant, non-standard corporate news, or potentially M&A Activity (TAR) if it involved a merger, but this is purely a distribution agreement. Given the nature of the announcement (a press release detailing a new commercial deal), RNS is the most appropriate general regulatory filing category.
2020-09-22 French
Information relative au nombre total de droits de vote et d'actions composant le capital au 31 août 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions composant le capital au 31 août 2020" (Information relative to the total number of voting rights and shares comprising the capital as of August 31, 2020). It explicitly states that the company is publishing this information in accordance with French commercial code articles concerning the total number of voting rights and shares. This type of mandatory periodic disclosure detailing the total share count and voting rights is typically classified as a Major Shareholding Notification (MRQ) or sometimes falls under general Regulatory Filings (RNS) if a more specific category isn't available. Since the core content is the official count of shares and voting rights as of a specific date, MRQ is the most appropriate fit, as it relates to changes in the capital structure's voting power base, even if it's a routine update. It is not an earnings release (ER), an interim report (IR), or a director's dealing (DIRS).
2020-09-01 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.